myeloproliferative disorders and myelodysplastic syndromes (MDS). Together with deletions of chromosome 5q and chromosome 7q. chromosome 20q deletions have previously been thought t o be restricted t o myeloid cells in patients with MDS. We report here that deletion of chromosome 20q in MDS can arise in a multipotent precursor of both myeloid cells and B cells. Clonal Epstein-Barr virus (EBV)-transformed cell lines, both with and without a 20q deletion, have been isolated from a patient with MDS. Moreover, these cell lines have been shown t o provide a useful physical mapping tool and have been used t o confirm the interstitial nature of the 20q deletion. Microsatellite poly-YELODYSPLASTIC syndromes (MDS) represent a heterogeneous collection of acquired clonal disorders characterized by cytopenia, morphologic dysplasia, and ineffective hematopoiesis. Several lines of evidence suggest that these disorders result from clonal expansion of abnormal multipotent hematopoietic progenitor cells. Early studies of two C6PD heterozygotes showed that a single isoenzyme was expressed in multiple hematopoietic lineages.',' These results have been extended by cytogenetic or molecular analysis of chromosome markers3" and more recently by various molecular techniques, including identification of RAS point rnutation~~.~ and the use of X-linked polymorphisms.'"' Peripheral blood granulocytes and monocytes have been shown to be part of the neoplastic clone in most patients in whom these have been studied. Erythroid cells and platelets have been studied in far fewer cases but, where studied, they have also been found to be derived from the abnormal c10ne.I.~ By contrast, the involvement of lymphoid cells is much more controversial. Several reports have suggested that peripheral blood lymphocytes,8~'' B cells?" or T cell^'^'^^^^ may be part of the malignant clone. However, deletions of chromosomes 5, 7, and 20 have all been reported to be restricted to myeloid Moreover, X-linked polymorphisms have been used to show that lymphoid cells are polyclonal in some cases.".12 The reasons for these contrasting results are unclear, but it has been suggested that they may reflect heterogeneity of progenitor cell involvement in different patients with MDS.6*'' Deletion of an F-group chromosome associated with polycythaemia rubra vera was first described by Kay et all5 and subsequently identified as chromosome 20. Deletions of 2Oq have subsequently been found in 10% to 15% of patients with PRV'6"8 and in a variable number of patients with myelofibr~sis'~~'~ or other myeloproliferative disorders." Although more common in the myeloproliferative disorders, deletions of 2Oq are also found in approximately 5% of patients with MDS and in some patients with acute myeloid leukemia,2"21 but only rarely in association with lymphoid malignancy. ' Cell separation. One hundred milliliters of venous blood was taken into EDTA and processed within 24 hours of collection. Granulocytes and mononuclear cells were separated using density gradient centrifugation with Histopaque 1077 (Sigma, St Louis, MO). Granulocytes were isolated from the pellet using an alkaline lysis method. T lymphocytes were isolated from the mononuclear fraction by rosetting with 2-aminoethylisothiouronium bromide hydrobromide (AET)-treated sheep erythrocyte^.^^ The purity of fractions was 90% or greater in both cases, as evaluated morphologically using a rapid Field's stain (BDH, Poole, UK) on cytospin preparations. High molecular weight DNA was extracted from both fractions using standard techniques.
Granulocytes and mononuclear cells, obtained as described above, were washed with phosphate-buffered saline and incubated with the appropriate fluorescein-conjugated monoclonal antibody (MoAb) (Dako, Glostrup, Denmark). Pure populations of granulocytes (CD15+), monocytes (CD14+), T lymphocytes (CD3+), and B lymphocytes (CD19+) were obtained using a FACS-Star Plus (Becton Dickinson, Mountain View, CA). Aliquots of 1, OOO cells were deposited in 200 pL of autoclaved water, boiled for 5 minutes, and then stored at -20°C.
EBV transformation of B lymphocytes. Mononuclear cells were aseptically obtained from a 10-mL aliquot of venous blood using density gradient centrifugation with Histopaque 11 19 (Sigma). The cells were washed once in RPMI 1640 before incubation for 4 hours at 37°C with 1 mL of culture supernatant from the EBV producer cell line B95-8.'5 The cells were then resuspended in RPMI 1640 supplemented with 20% fetal calf serum (FCS) and 10 pg/mL phytohemagglutinin (PHA) and dispensed into a 24-well plate at lo6 cells per well. Cultures were fed at 4-day intervals with RPMI 1640,20% FCS. Positive wells were expanded 3 to 4 weeks after exposure to the virus.
In some experiments EBV-transformed cells were cloned by limiting dilution immediately after exposure to EBV. Cells were infected as described above and subsequently dispensed into 96-well microtiter plates precoated with mouse peritoneal macrophages (1 @/well) obtained by peritoneal lavage of female BalWc mice. Lymphoid cells were seeded at 103, 104, IO5, and IO6 cells per well. The plates were fed at 4-day intervals with RPMI 1640 containing 20% FCS and 25% human tonsil conditioned medium (see below). Positive wells were screened for the presence of the deletion using polymerase chain reaction ( E R ) .
Cloning of cell lines. EBV-transformed cell lines were cloned by limiting dilution in round-bottomed 96-well microtiter plates precoated with mouse peritoneal macrophages (l@/well). A single-cell suspension was prepared from each cell line, checked microscopically, and dispensed at varying cell densities into 96-well plates. The plates were fed at 4-day intervals with RPMI 1640 containing 20% FCS and supplemented with 25% human tonsil-conditioned medium. Positive wells were expanded from microtiter plates containing at least 70% negative wells and were screened for the presence of the deletion cytogenetically.
Human tonsils obtained from routine tonsillectomy were disaggregated aseptically in RPMI 1640 using wire mesh. Lymphocytes were separated using density gradient centrifugation with Histopaque 11 19. The mononuclear cells were washed twice with RPMI 1640 before counting and diluting to a density of 1 X IO6 cells/mL in RPMI 1640, 20% FCS, penicillin, streptomycin, and gentamicin. They were then incubated for 48 hours at 37°C in the presence of 5% COz. Media were harvested by centrifugation, followed by filtration through a 0.2 pm cellulose filter and stored at -20°C.
Cytogenetic analysis. Cells were harvested by conventional methods 24 hours after the initiation of cultures and at intervals thereafter. Slides were G-banded with Wright's stain. High resolution chromosome banding analysis was performed with the aid of a computer-based image analysis system (Smartcapture; Digital Scientific, Cambridge, UK). The International System for Human Cytogenetic Nomenclature has been used.36
Cytochemistry and immunophenotype. Stains for acid phosphatase, periodic acid Schiff, and Sudan Black were performed using routine techniques3' Indirect immunofluorescence staining for all surface antigen expression was performed using standard methods before analysis using a fluorescence-activated cell sorter (FACS) (Coulter Electronics Elite; Coulter Electronics, Hialeah, K). The following MoAbs were used W-l0 (CD2). DK23 (CD5), SS2-36 (CDlO), HD37 (CD19). H299 (CD20), 4KB 128 (CD22). ACT-l (CD25), TI6 (CD38), FMC7, R1169 (IgM), A8 B5 (kappa), and NI012 (lambda).
PCR analysis. Forty-nanogram aliquots of DNA from the cell lines, granulocytes, and T lymphocytes were each amplified in 50 pL of a mixture containing buffer (50 mmol/L KCl, 10 mmol/L Tris HC1 pH 8.3, 1.5 mmoVL MgCl,, 0.1 % gelatine), dNTPs (250 pmoll L each), primers (50 pmol each), and Cetus Taq polymerase (0.5 U; Perkin Elmer Cetus, Norwalk, CT). In all cases 1/10 v01 of the lefthand primer was end-labeled with "P dATP using polynucleotide kinase. Samples were amplified in an MG Research (Watertown, MA) programmable thermal controller for 35 cycles (40 seconds, 94°C; 30 seconds 55°C). The following primer pairs (sequences kindly communicated by J. Weissenbach, Genethon, Paris, France) were used to examine the cell lines: one above the centromeric breakpoint (AFM294zc5a, AAGCACAGGTAGTTGTAACATGG; AFM294zc5b, CCAGTCCCTTGCTGTCATAATA); one within the deletion (AFM238vh6a. CTTGGGACTTGTCAGCCTC; AFM238-vh6b, TCTTAACTTCTGCCCCTTG); and one below the telomeric breakpoint (AFM276xhla, "TACTAAGGAGACTCAACAGG; AFM276xhlb, TTGCACAATGCCTGGAA). The amplified products were visualized by denaturing polyacrylamide gel electrophoresis followed by autoradiography.
For analysis of FACS-sorted cells, DNA was purified from each aliquot of 1 Abbreviations: T, PHA-stimulated blood mononuclear cells: MHlA-D, independent EBV-transformed cell lines.
followed by ethanol precipitation with 0.1 pmol glycogen as a carrier molecule. The DNA from each aliquot was resuspended in 50 pL of PCR solution and amplification was performed as detailed above, but with 60 cycles.
PCR analysis of the PCK gene was performed as described previously. DNA was purified from the cell lines, granulocytes, and T lymphocytes using standard phenokhloroform extraction and ethanol precipitation techniques. Ten nanograms of DNA was then divided into two aliquots, one of which was digested with 50 U of 38 Thirty cycles of amplification were performed using the above conditions. The buffer was then exchanged to allow digestion with BsrXI (55°C. 3 hours). PCR products were visualized by electrophoresis in a 2% agarose gel followed by staining with ethidium bromide.
For analysis of FACS-sorted cells, DNA was purified from each aliquot of 1,OOO cells using standard phenokhloroform extraction followed by ethanol precipitation with 0.1 pmol glycogen as a carrier molecule. The DNA was divided into two aliquots, one of which was digested with 50 U of the methylation-sensitive enzyme, HpaII, at 37°C for 3 hours. Both aliquots were then amplified as detailed above but with two 60-cycle reactions.
RESULTS
Generation of a lyrnphoblastoid cell line carrying a 20q deletion. Cytogenetic analyses of BM from this patient in 1989 and 1992 showed a del 20q (1 1.2-q 13.1) in all metaphases examined (Table l, Fig l) . No other structural or numerical chromosome abnormality was detected. To search for the presence of an occult translocation involving chromosome 20 that might mimic a deletion, FISH was performed on the patient's BM metaphases using a chromosome 20 paint (Cambio, Cambridge, MA). A fluorescent signal was detected along the whole length of each chromosome 20 homologue and on no other chromosome (data not shown). This provided strong evidence against the presence of an occult reciprocal translocation involving chromosome 20.
Peripheral blood mononuclear cells were exposed to EBV and then immediately dispensed at a density of lo6 cells per well. Cell lines were obtained from four independent wells and their karyotypes were analyzed 10 weeks after transformation. As shown in Table 1 , two of the lines (MHlB, MHlD) gave rise to significant numbers of metaphases containing a 20q deletion, whereas only normal metaphases were observed in the remaining two lines (MH 1 A, MH IC). MHlB and MHlA were subsequently cloned by limiting dilution to give rise to MHlB14 and MHl Al. Cytogenetic analysis of the chromosome 20 homologs present in MHlB 14 and MHlAl clearly demonstrated a 20q deletion in the former cell line, which was morphologically identical to the 20q deletion present in the patient's BM metaphases (Fig l) .
May-Grihwald-Giemsa staining of MH I B 14 and MH 1A 1 showed lymphoblastoid morphology with no significant difference between the two cell lines. Both cell lines were positive for acid phosphatase and the periodic acid Schiff stain but were negative for Sudan Black. FACS analysis showed both cell lines to be positive for CD 19, CD20, CD22, and CD38 but negative for CD2, CD5, CDlO, CD25, FMC7, IgM, kappa, and lambda (data not shown). These results confirm the B-cell nature of both MHIB14 and MHlAl.
The 20q deletion is interstitial. To characterize the deletion at a molecular level, microsatellite PCR was used. Sev- Primer A Primer B Primer C era1 PCR primer pairs for polymorphic microsatellite repeats on 20q were tested using DNA from MHI A to determine whether they were informative in this patient. Three informative primer pairs were then used to amplify DNA from MHIB14 and MHIAI. The smaller allele detected by AFM238vh6 was clearly absent from MHI B 14, thus localizing this locus within the deletion. By contrast, both alleles detected by AFM294zcS and AFM276xh1 are retained in MHlB 14 (Fig 2) . Because AFM294zcS and AFM276xh1 are centromeric and telomeric, respectively, with respect to AFM238 vh6 (Fig 2) , these data show that the 20q deletion in this patient is interstitial. Moreover, they show that MHlB 14 and MHI AI will prove useful for the physical mapping of this 20q deletion. Lineage involvement of the 20q deletion. To determine whether microsatellite PCR could be used to study the lineage involvement of the 20q deletion in purified peripheral blood cell populations, it was necessary to determine the sensitivity of microsatellite PCR in the presence of contaminating normal cells. Therefore, DNA was extracted from MHIB14 and mixed with varying amounts of DNA from MHI Al. As shown in Fig 3, the ratio of the intensity of the lower allele to that of the upper allele was clearly reduced, even in the presence of 30% normal cells.
Therefore, purified blood cell populations were prepared and analyzed using AFM238vh6 primers (Fig 4A) . DNA from T cells separated by a sheep red blood cell rosetting method gave rise to alleles of equal intensity. By contrast, DNA from granulocytes purified by density-gradient centrifugation consistently produced a lower allele of reduced intensity. The residual lower allele amplified from granulocyte DNA was thought to reflect the presence of contaminating lymphocytes andor the presence of a subpopulation of nonclonal granulocytes. To investigate this further, different cell populations were separated by FACS and analyzed using the same primer pair (Fig 4B) . Granulocytes and monocytes clearly carried the deletion, whereas it was not detected in either B cells or T cells.
Absence of the deletion in purified T cells accorded with the cytogenetic analysis of PHA-stimulated peripheral blood mono- 1 and 2, respectively) 
: PCK1
However, although microsatellite PCR failed to detect the deletion in peripheral blood B cells, cytogenetic analysis of EBVtransformed cell lines showed two of four to contain metaphases with a 20q deletion. These cell lines were generated by dispensing l@ cells per well, and so each independent cell line is likely 1 2 3 4 5 nuclear cells, which showed only normal metaphases (Table  l) .
MHlB14.
use only.
For to represent multiple transformation events. The possibility of selection for or against lymphoblastoid cells carrying the 2Oq deletion in such polyclonal populations rendered it tliflicult to infer from these results the prevalence of peripheral blood R cells carrying the 2Oq deletion.
To address this question. ERV transfonnation was repeated and. on this occasion. the transformed cells were cloned immediately by limiting dilution. Cell lines were only expanded from microwcll plates containing cells dispcnscd at a dilution that prtxluced greater than 70% negative wells. Sixteen cell lines obtained in this manner were characterized by microsatellitc PCR with AFM23Xvhh primcrs. Interestingly. all 16 independent cell lines carried the deletion (Fig S) .
Taken together. these data show that the majority of ERVtnmsformed lymphoblastoid cells contained the 20q delction 1 2 3 4 5 6 7 8 9 1 0
. even though the deletion was not detected in purified peripheral blood R cells. These observations raise the possibility that R cells derived from the myelcdysplastic clone may be preferentially transformed by ERV or may survive better after transfomlation.
Clorrdiry of c/;jierent /inea,qes. This patient w a s heterozygous for the RsfXI polymorphism of the PGK gene. Therefore. clonality of different purified cell populations was assessed by PCR. X-chromosome inactivation was unilateral and involvcd the same allele in peripheral blood granulocytes. monocytes. and the MHI B14 cell line. Ry contrast. a polyclonal pattern uw clearly seen in B cells and T cells (Fig 6) . .h' The lineage involvement of trisomy 8 has been studied by FISH in three patients with MDS.'9 Trisomy 8 was seen in various proportions of granulocytes, monocytes, eosinophils, and basophils, but not in lymphocytes. We are aware of only one previous example of a chromosome deletion detected in B cells in MDS. Lawrence et all3 reported two patients with acquired idiopathic sideroblastic anemia and a 13q deletion. The 13q deletion was detected in BM metaphases and also in a minority of metaphases derived from EBV-transformed cultures. However, no clonal cell line containing the 13q deletion was reported and so the nature of the dividing cells carrying the 13q deletion in the EBV-transformed cultures was not confirmed. In addition to chromosome markers, a number of other approaches have been used to assess whether lymphoid cells are derived from the neoplastic clone in patients with MDS. Wainscoat et a14" reported absence of IgH and TCR rearrangements in peripheral blood lymphocytes as assessed by Southern blotting. More recently Culligan et all2 detected CDR 3 rearrangements by PCR in a minority of MDS patients, but not in age-matched controls. However, there are several problems with these approaches. Even if lymphoid cells were derived from the malignant clone, they may well have undergone independent antigen receptor rearrangement events and thus appear polyclonal. Furthermore, immunologic abnormalities are well recognized in MDS4' and these may predispose to oligoclonal or monoclonal lymphoid expansions that are unrelated to the neoplastic clones. The use of X-linked polymorphisms represents a more informative approach but has produced conflicting results in patients with MDS. G6PD isoenzyme analysis in two heterozygous patients has shown the same isoenzyme in lymphoid and myeloid cells.'.2 Janssen et a19 have also demonstrated the involvement of T and B cells in two patients with chronic myelomonocytic leukemia (CMML) using an assay for RAS gene point mutations. However, analysis of X-linked restriction fragment length polymorphisms has been reported to show T or B cells derived from the malignant clone in some patients'"."." but not in There are probably several explanations for the conflicting data. First, extreme lyonization is now recognized to occur in a significant minority of normal ~o m e n .~~.~' Therefore, appropriate controls are vital before assuming that unilateral inactivation reflects monoclonality.M~45 Second, different techniques used to assess lymphoid involvement vary greatly in their sensitivity. Minor populations of lymphoid cells derived from the neoplastic clone may escape detection in many cases. Third, there may exist heterogeneity in the level of the multipotent progenitor involved in different patients with MDS. It has been suggested that the transformed cell may be myeloid restricted in some patients but in others be capable of giving rise to both lymphoid and myeloid progenitors.6I2
Our data are particularly relevant to the latter two issues. In the patient reported here, peripheral blood B cells were polyclonal (Fig 6) and the 20q deletion was not detected in highly purified B cells (Fig 4B) . Since mixing experiments showed that the 20q deletion was readily detectable (reduced intensity of lower allele), even in the presence of 30% normal cells (Fig 3) , these results suggest that the 20q deletion is only carried by a minority of peripheral blood B cells. However, EBV transformation with immediate limiting dilution showed that 16 of 16 EBV-transformed lymphoblastoid cell lines carried the 20q deletion (Fig 5) . These apparently paradoxical results could reflect preferential expression of CD21 Our data also clearly show that the 20q deletion in this patient arose in a progenitor capable of giving rise to granulocytes, monocytes, and B cells. However, we could find no evidence of the deletion in T cells by microsatellite PCR.
Moreover, 50 PHA-stimulated metaphases were analyzed cytogenetically and none contained a 20q deletion. There are two broad explanations for these observations. First, the 20q deletion may have arisen in a progenitor capable of giving rise to myeloid cells, B cells, and T cells. In this case our inability to detect T cells carrying the 20q deletion may reflect one or more of the following: (1) the unresponsiveness to PHA of T cells carrying the 20q deletion; (2) the methods used were not sensitive enough to detect a very small proportion of T cells carrying the 20q deletion; or (3) the 20q deletion itself inhibits differentiation along the T-cell lineage. Second, the 2% deletion may have arisen in a progenitor capable of giving rise to myeloid cells and B cells but not to T cells. There is mounting evidence for a close association between B cells and myeloid cells. B-cell lines have been reported to generate macrophage-like ~e l l s .~* ,~~ Furthermore, multipotent human5' and m~r i n e~' ,~* progenitors capable of giving rise to B cells and myeloid cells have recently been identified. Therefore, our results suggest that at least some of the reported heterogeneity at the level of the transformed progenitor in different patients with MDS may be more apparent than real. In this patient both the 20q deletion and unilateral X inactivation were apparently restricted to myeloid cells, and yet the neoplastic clone clearly arose in a multipotent cell capable of giving rise to B cells. It remains to be seen how many other patients, described as having unilateral X inactivation or a chromosome marker restricted to the myeloid lineage, in fact have a disease arising in a multipotent cell with both myeloid and lymphoid potential. 
